ArticleCancer chemotherapy and pharmacology2022

Abemaciclib is synergistic with doxorubicin in osteosarcoma pre-clinical models via inhibition of CDK4/6-Cyclin D-Rb pathway.

Deli Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.